Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 29 FEBRUARY 2016

Regulatory Update: Maryland Changes Exemption Filing Rules!

Fox Rothschild LLP
Fox Rothschild LLP
Contributor
Explore more from Fox Rothschild LLP

Other than the Form F-1 and an applicant's cover letter, if an applicant chooses to include a cover letter, no paper documents should be filed as part of a notice of claim of exemption.

United StatesCorporate/Commercial Law
Eleanor Gerhards
Eleanor Gerhards
Author LinkedIn connections

 Last Friday, the Maryland Office of the Attorney General issued an interpretative opinion/no-action position allowing franchisors to file notice of claims of exemption under the Maryland Franchise Registration and Disclosure Law on CD-ROM without including paper copies. The new procedure goes into effect on March 1st. According to the state, "allowing franchisors to file notices of claims of exemption on CD-ROM. . . simplifies the filing procedures for those franchisors, reduces costs and storage requirements for filers and the Securities Division, and saves environmental resources. In addition, these streamlined procedures do not compromise the Securities Division's review or recordkeeping functions and have no impact on prospective franchise investors."

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

Related Comparative Guides

See more popular content from

Article

Healthcare Trends & Transactions Q2 2026

Healthcare M&A activity maintained steady momentum through Q2 2026, driven by physician practice consolidation, AI-enabled technology acquisitions, and strategic outpatient expansion. Private equity investment persisted despite intensifying regulatory scrutiny of MSO arrangements, while digital health buyers paid significant premiums for platforms demonstrating production-grade AI capabilities and proprietary data assets.
United StatesCorporate/Commercial Law
Bass, Berry & Sims PLC
Bass, Berry & Sims PLC
Article

CLIENT ALERT: 2026 Mid-Year Update On SEC And CFTC Enforcement

The SEC and CFTC have fundamentally shifted their enforcement approach in 2026, moving away from high-volume technical violations toward targeted actions addressing serious fraud and market manipulation. This mid-year update examines new leadership priorities, enhanced inter-agency coordination, revised cooperation policies, the elimination of "no-deny" settlement provisions, and a landmark Supreme Court ruling on disgorgement that collectively reshape the regulatory landscape for market participants.
United StatesCorporate/Commercial Law
Sher Tremonte
Sher Tremonte
Article

Sanofi And Regeneron Expand Immunology Collaboration In Deal Worth Up To $8 Billion

Sanofi and Regeneron Pharmaceuticals announce a major expansion of their immunology partnership, committing up to $8 billion to develop and commercialize four long-acting antibodies targeting key inflammatory pathways. The collaboration includes a $1 billion upfront payment and milestone-based payments, with both companies sharing development costs and future profits equally.
United StatesCorporate/Commercial Law
Goodwin Procter LLP
Goodwin Procter LLP